DVYSR.ST
Price:
$102
Market Cap:
$1.68B
Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-12-10
Stock Exchange
STO
Ticker
DVYSR.ST
According to Devyser Diagnostics AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -24.06. This represents a change of -57.93% compared to the average of -57.19 of the last 4 quarters.
The mean historical PE Ratio of Devyser Diagnostics AB (publ) over the last ten years is -17.58. The current -24.06 PE Ratio has changed 13.59% with respect to the historical average. Over the past ten years (40 quarters), DVYSR.ST's PE Ratio was at its highest in in the March 2023 quarter at -14.41. The PE Ratio was at its lowest in in the December 2024 quarter at -152.94.
Average
-17.58
Median
-23.37
Minimum
-48.00
Maximum
4.98
Discovering the peaks and valleys of Devyser Diagnostics AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 20.18%
Maximum Annual PE Ratio = 4.98
Minimum Annual Increase = -164.24%
Minimum Annual PE Ratio = -48.00
Year | PE Ratio | Change |
---|---|---|
2024 | -31.83 | 36.23% |
2023 | -23.37 | -6.34% |
2022 | -24.95 | -48.03% |
2021 | -48.00 | 20.18% |
2020 | -0.24 | -164.24% |
2019 | 0.37 | -92.60% |
The current PE Ratio of Devyser Diagnostics AB (publ) (DVYSR.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-26.71
5-year avg
-25.68
10-year avg
-17.58
Devyser Diagnostics AB (publ)’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Devyser Diagnostics AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Devyser Diagnostics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Devyser Diagnostics AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Devyser Diagnostics AB (publ) (DVYSR.ST)?
What is the highest PE Ratio for Devyser Diagnostics AB (publ) (DVYSR.ST)?
What is the 3-year average PE Ratio for Devyser Diagnostics AB (publ) (DVYSR.ST)?
What is the 5-year average PE Ratio for Devyser Diagnostics AB (publ) (DVYSR.ST)?
How does the current PE Ratio for Devyser Diagnostics AB (publ) (DVYSR.ST) compare to its historical average?